1-8 of 8
Katia B.B. Pagnano, MD
Close
Sort by
Journal Articles

Influence of BCR-ABL Transcript Type on Outcome in Patients with Chronic-Phase Chronic Myeloid Leukemia Treated with Imatinib 400 Mg

Katia B.B. Pagnano, MD PhD, Eliana Cristina Martins Miranda, PhD, Marcia T Delamain, MD, Gislaine OLIVEIRA Duarte, MD, Erich Vinicius De Paula, MD PhD, Valquiria Povoa, Bruna Rocha Vergilio, Irene Lorand-Metze, MD PhD, Carmino Antônio De Souza, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1911.
https://doi.org/10.1182/blood.V128.22.1911.1911
Published: 2016
Journal Articles

Assessment of Cardiovascular Events in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors

Katia B.B. Pagnano, MD PhD, Paola Morelato Assunção, MD, Roberto Zullli, Marcia T Delamain, MD, Gislaine OLIVEIRA Duarte, Irene Lorand-Metze, MD PhD, Carmino A De Souza, Sr., MD PhD
Journal: Blood
Blood (2015) 126 (23): 4031.
https://doi.org/10.1182/blood.V126.23.4031.4031
Published: 2015
Journal Articles

Gene Expression Profile in Responsive and Non-Responsive Chronic Myeloid Leukemia Patients Treated with Dasatinib.

Rosana A Silveira, MSc, Angela A Fachel, Yuri B Moreira, Marcia T Delamain, MD, Carmino Antonio De Souza, MD, PhD, Fernando Ferreira Costa, Ph.D., M.D., Sergio Verjovski-Almeida, MD, PhD, Katia B.B. Pagnano, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3260.
https://doi.org/10.1182/blood.V114.22.3260.3260
Published: 2009
Journal Articles

Brazilian Experience Using High Dose Sequential (HDS) Followed by Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Relapse/Refractory Aggressive Non-Hodgkin Lymphoma (NHL).

Bruno K.L. Duarte, MD, I.S. Valente, MD, Afonso C. Vigorito, MD, Francisco J.P. Aranha, MD, Gislaine B. Oliveria, MD, Eliana C.M. Miranda, Irene Lorand-Metze, PhD, Katia B.B. Pagnano, MD, Carmino A. De Souza, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 5102.
https://doi.org/10.1182/blood.V110.11.5102.5102
Published: 2007
Journal Articles

High Dose Sequential (HDS) Followed by Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Salvage Treatment of Hodgkin’s Disease (HD): A Brazilian Experience.

Bruno K.L. Duarte, MD, I.S. Valente, MD, Afonso C. Vigorito, MD, Francisco J.P. Aranha, MD, Gislaine B. Oliveira, MD, Eliana C.M. Miranda, Irene Lorand-Metze, PhD, Katia B.B. Pagnano, MD, Carmino A. De Souza, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 5103.
https://doi.org/10.1182/blood.V110.11.5103.5103
Published: 2007
Journal Articles

Screening of Mutations in BCR-ABL Kinase Domain in Chronic Myeloid Leukemia (CML) Patients Treated with Kinase Inhibitors by Denaturing High-Performance Liquid Chromatography (D-HPLC).

Cintia C. Mascarenhas, Anderson F. Cunha, Katia B.B. Pagnano, MD, Rosana A. Silveira, Fernando F. Costa, MDPhD, Ricardo Pasquini, MDPhD, Nelma C.D. Clementino, MDPhD, Carmino A. De Souza, MDPhD
Journal: Blood
Blood (2007) 110 (11): 4580.
https://doi.org/10.1182/blood.V110.11.4580.4580
Published: 2007
Journal Articles

Detection of BCR-ABL Point Mutations in Patients with Chronic Myeloid Leukemia (CML) Resistant to Imatinib.

Rosana A. Silveira, Dulcineia M. Albuquerque, PhD, Angela M. Assis, Edson Ichihara, Carmino A. de Souza, MD,PhD, Fernando F. Costa, MD,PhD, Marcia T. Delamain, MD, Afonso C. Vigorito, MD,PhD, Irene Lorand-Metze, MD,PhD, Eliana Miranda, Katia B.B. Pagnano, MD,PhD
Journal: Blood
Blood (2006) 108 (11): 4817.
https://doi.org/10.1182/blood.V108.11.4817.4817
Published: 2006
Journal Articles

High Frequency of Point Mutations of BCR/ABL Gene in CML Patients Resistant to Imatinib Therapy - Report of a Novel Mutation.

Edson Ichihara, Fernando F. Costa, MD, Natasha Busoli, Dulcineia M. Albuquerque, Irene Lorand-Metze, MD, Sara T.O. Saad, MD, Carmino A. De Souza, MD, Afonso C. Vigorito, MD, Katia B.B. Pagnano, MD
Journal: Blood
Blood (2004) 104 (11): 4661.
https://doi.org/10.1182/blood.V104.11.4661.4661
Published: 2004